US Research Institute says Bharat Biotech’s Covaxin Effective against Delta type Coronavirus
Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), effectively neutralizes both Alpha and Delta variants of coronavirus, revealed the studies recently conducted by the US National Institute of Health (NIH), the top American health research institute.
Two studies - Study 1 and Study 2 - were conducted in which blood serum was collected and screened from people receiving Covaxin. The results show that the vaccine generates antibodies that effectively neutralize the B.1.17 (alpha) and B.1.617 (delta) variants of SARS-CoV-2, previously identified in the UK and India, respectively. NIH said.
https://youtu.be/26tp5Gzl8n8
SARS-CoV-2 is a virus that causes Covid-19 Disease
Covaxin comprises a disabled form of SARS-CoV-2 that cannot repli...